Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
17.73
-0.15 (-0.84%)
Last updated: Aug 27, 2025

Frontier Biotechnologies Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
6,4733,6563,7166,4656,6886,925
Upgrade
Market Cap Growth
35.77%-1.61%-42.53%-3.33%-3.43%-
Upgrade
Enterprise Value
6,1083,4423,0555,3915,3186,738
Upgrade
Last Close Price
17.289.769.9217.2618.5919.25
Upgrade
PS Ratio
48.6128.2432.5276.29165.12148.54
Upgrade
PB Ratio
5.903.202.773.873.653.24
Upgrade
P/TBV Ratio
6.793.693.344.574.263.74
Upgrade
EV/Sales Ratio
45.8726.5926.7463.61131.30144.52
Upgrade
Debt / Equity Ratio
0.350.360.280.170.160.02
Upgrade
Asset Turnover
0.070.070.050.030.020.03
Upgrade
Inventory Turnover
1.941.911.421.471.912.58
Upgrade
Quick Ratio
2.442.812.654.643.7616.07
Upgrade
Current Ratio
2.723.092.905.073.9516.40
Upgrade
Return on Equity (ROE)
-15.92%-16.21%-21.83%-20.38%-13.36%-17.17%
Upgrade
Return on Assets (ROA)
-8.70%-8.76%-9.45%-10.08%-7.95%-8.88%
Upgrade
Return on Capital (ROIC)
-10.48%-10.58%-11.71%-12.23%-9.35%-10.90%
Upgrade
Earnings Yield
-2.93%-5.51%-8.85%-5.52%-3.89%-3.33%
Upgrade
FCF Yield
-3.14%-5.23%-10.67%-6.64%-8.53%-5.15%
Upgrade
Buyback Yield / Dilution
0.01%0.24%-2.69%-0.79%-25.23%-9.40%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.